Rinsho Shinkeigaku (Clinical Neurology)

Case Report

Good response to intravenous immunoglobulin therapy in sensory dominant distal variant of chronic inflammatory demyelinating polyneuropathy

Yukio Takeshita, M.D., Michiaki Koga, M.D., Masatoshi Omoto, M.D., Jun-ichi Ogasawara, M.D., Motoharu Kawai, M.D. and Takashi Kanda, M.D.

Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine

A 46-year-old man experienced numbness and muscle weakness in the distal portions of both hands, which progressed over following three months. Neurological examination showed mild muscle weakness only in distal arms, hypoflexia or areflexia, and hypesthesia in glove and stocking distribution. Motor conduction study revealed markedly prolonged distal latency and abnormal temporal dispersion. Sensory nerve potentials were reduced or could not be recorded. Histopathlogical findings of the sural nerve showed several nerve fibers with thinning myelin sheath and mild reduction of myelinated fibers. These results suggested the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Two weeks after intravenous immunoglobulin therapy, neurological deficits rapidly improved and electrophysiological abnormalities were also ameliorated. Thereafter, there was no clinical deterioration for two years without further treatment. Our patient suggested that immunomodulating treatment is needed for stopping the initial progression of neurological deficits, but maintenance therapy is not always necessary for keeping the remitting state in distal variant of CIDP.
Full Text of this Article in Japanese PDF (375K)

(CLINICA NEUROL, 51: 478|482, 2011)
key words: chronic inflammatory demyelinating polyneuropathy, distal variant, intravenous immunoglobulin, distal acquired demyelinating symmetric neuropathy

(Received: 14-Oct-10)